Velocity Clinical Research Luebeck GmbH

The medical center is at the forefront of research in respiratory diseases, focusing on innovative treatments for conditions such as bronchiectasis and chronic obstructive pulmonary disease (COPD). Through extensive clinical trials, the center is exploring new therapeutic options to improve patient outcomes and quality of life.

• Bronchiectasis
• Chronic Obstructive Pulmonary Disease (COPD)
• Severe Asthma

By conducting trials on medications like BI 1291583 and astegolimab, the center is contributing to the development of safer and more effective treatments for these challenging conditions.

Specializing in the management of chronic cough, the center is dedicated to understanding and alleviating this often debilitating condition. Research efforts are directed towards evaluating the efficacy of novel treatments such as BLU-5937 and Taplucainium Inhalation Powder.

• Refractory Chronic Cough
• Unexplained Chronic Cough

These studies aim to provide relief for patients suffering from persistent coughs, enhancing their daily lives and overall health.

The center is also a leader in asthma research, particularly in severe cases. By investigating the effects of treatments like verekitug (UPB-101), the institution is working to reduce asthma exacerbations and improve patient management strategies.

• Severe Asthma

These efforts are crucial in developing targeted therapies that can significantly impact the lives of those with severe asthma, offering hope for better control and fewer complications.